No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /

No. 1 - 100 Paclitaxel Patents:

	PAT. NO.		Title
1	6,515,151		Method for the preparation of novel sidechain-bearing taxanes and intermediates thereof
2	6,515,017		Water soluble paclitaxel derivatives
3	6,515,016		Composition and methods of paclitaxel for treating psoriasis
4	6,515,009		Therapeutic inhibitor of vascular smooth muscle cells
5	6,515,004		N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
6	6,514,983		Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
7	6,514,738		KinI-3 motor protein and methods for its use
8	6,514,535		Bioadhesive hydrogels with functionalized degradable crosslinks
9	6,514,491		Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10	6,514,193		Method of administering a therapeutically active substance
11	6,512,123		Tricyclic alkylhydroxamate derivatives
12	6,511,973		Lactam inhibitors of FXa and method
13	6,511,676		Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
14	6,509,491		Aminohydroxylation of olefins in the presence of acetamide
15	6,509,484		Synthesis of taxol, taxol analogs and their intermediates with variable a-ring side chain structures and compositions thereof
16	6,509,370		Paclitaxel formulation
17	6,509,316		Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer
18	6,506,910		Process for preparing discodermolide and analogues thereof
19	6,506,905		Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid
20	6,506,799		Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds
21	6,506,798		4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors
22	6,506,783		Cancer treatments and pharmaceutical compositions therefor
23	6,506,437		Methods of coating an implantable device having depots formed in a surface thereof
24	6,506,411		Anti-angiogenic compositions and methods of use
25	6,506,408		Implantable or insertable therapeutic agent delivery device
26	6,506,405		Methods and formulations of cremophor-free taxanes
27	6,506,399		Biodegradable botulinum toxin implant
28	6,503,954		Biocompatible carrier containing actinomycin D and a method of forming the same
29	6,503,893		Method of treating hyperproliferative diseases using active vitamin D analogues
30	6,503,556		Methods of forming a coating for a prosthesis
31	6,503,481		Compositions for aerosolization and inhalation
32	6,503,396		Method and apparatus for preparing taxol using supercritical fluid from source materials
33	6,503,184		Human tumor necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2
34	6,500,966		Process for the preparation of taxanes from 10-deacetylbaccatin III
35	6,500,868		Method for preventing and treating peripheral neuropathy by administering selegiline
36	6,500,858		Taxoid anti-tumor agents and pharmaceutical compositions thereof
37	6,500,853		Inhibitors of phospholipase enzymes
38	6,500,461		Particulate formulations
39	6,500,431		Inhibitors of angiogenesis and tumor growth
40	6,500,405		Use of certain amides as probes for detection of antitubulin activity and resistance monitoring
41	6,498,945		Sonodynamic therapy using an ultrasound sensitizer compound
42	6,498,257		2,3-olefinic epothilone derivatives
43	6,498,195		Use of 1-propanone-1-(2,4-dihydroxyphenyl)-3-hydroxy-3-(4'-hydroxyphenyl) as an anticarcinogenic agent
44	6,498,188		Methods of treatment for cancer or viral infections
45	6,497,904		Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent
46	6,495,719		Histone deacetylase inhibitors
47	6,495,705		Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
48	6,495,663		Method and composition for enhancing transport across biological membranes
49	6,495,659		Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
50	6,495,600		Method and composition for selectively inhibiting melanoma

51	6,495,594		Biologically active analogs of discodermolide
52	6,495,579		Method for treating multiple sclerosis
53	6,495,571		Pyridine compounds, use and preparation thereof
54	6,495,553		Methods and compositions for overcoming resistance to biologic and chemotherapy
55	6,495,520		Apoptosis Inducing Molecule II and methods of use
56	6,495,161		Cytoprotective biocompatible containment systems for biologically active materials and methods of making same
57	6,495,129		Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
58	6,494,862		Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway
59	6,492,547		Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof
60	6,492,379		Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
61	6,491,938		Therapeutic inhibitor of vascular smooth muscle cells
62	6,489,447		Protein purification
63	6,489,369		Phosphocholine surfactants and their use
64	6,489,314		Epothilone derivatives and methods for making and using the same
65	6,488,962		Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
66	6,486,204		Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug
67	6,486,202		Inhibitors of isoprenyl transferase
68	6,486,146		Cancer accelerants and phase synchronization methods
69	6,485,737		Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles and methods of using the same
70	6,485,514		Local delivery of therapeutic agents
71	6,482,932		Nucleoside triphosphates and their incorporation into oligonucleotides
72	6,482,860		Pentafluorobenzenesulfonamides and analogs
73	6,482,850		Hydrolysis-promoting hydrophobic taxane derivatives
74	6,482,843		Compounds and methods for use thereof in the treatment of cancer or viral infections
75	6,482,842		3-aminopyrazole inhibitors of cyclin dependent kinases
76	6,482,830		Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
77	6,482,802		Use of neomycin for treating angiogenesis-related diseases
78	6,482,517		Coated particles, methods of making and using
79	6,482,439		Drug delivery system exhibiting permeability control
80	6,482,436		Magnetically responsive composition
81	6,479,679		Two-step conversion of protected taxane ester to paclitaxel
82	6,479,512		Tyrosine kinase inhibitors
83	6,479,500		Agents for alleviating side effects
84	6,479,499		2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
85	6,479,481		Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
86	6,479,471		NAALADase inhibitors
87	6,479,254		Apoptosis inducing molecule II
88	6,479,068		Therapeutic nutrient regimen for alleviating mucositis, stomatitis and cachexia in oncology patients
89	6,479,067		Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
90	6,478,776		Implant delivery catheter system and methods for its use
91	6,476,242		2-aroyl-4-acyl paclitaxel (Taxol) analogs
92	6,476,203		Safe pharmaceutical composition for treating and preventing infertility and increasing immune function
93	6,476,195		Secreted protein HNFGF20
94	6,476,068		Platinum derivative pharmaceutical formulations
95	6,476,066		Anti-first-pass effect compounds
96	6,475,753		94 Human Secreted Proteins
97	6,475,516		Drug delivery via therapeutic hydrogels
98	6,472,585		Cardiotrophin-1 defective mouse
99	6,472,541		Protecting groups with increased photosensitivities
100	6,472,512		Keratinocyte derived interferon

No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /